Piras, A.M.; Zambito, Y.; Lugli, M.; Ferro, B.; Roncucci, P.; Mori, F.; Salvatore, A.; Ascione, E.; Bellini, M.; Crea, R.
Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics. Pharmaceuticals 2020, 13, 425.
https://doi.org/10.3390/ph13120425
AMA Style
Piras AM, Zambito Y, Lugli M, Ferro B, Roncucci P, Mori F, Salvatore A, Ascione E, Bellini M, Crea R.
Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics. Pharmaceuticals. 2020; 13(12):425.
https://doi.org/10.3390/ph13120425
Chicago/Turabian Style
Piras, Anna Maria, Ylenia Zambito, Maurizio Lugli, Baldassare Ferro, Paolo Roncucci, Filippo Mori, Alfonso Salvatore, Ester Ascione, Marta Bellini, and Roberto Crea.
2020. "Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics" Pharmaceuticals 13, no. 12: 425.
https://doi.org/10.3390/ph13120425
APA Style
Piras, A. M., Zambito, Y., Lugli, M., Ferro, B., Roncucci, P., Mori, F., Salvatore, A., Ascione, E., Bellini, M., & Crea, R.
(2020). Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics. Pharmaceuticals, 13(12), 425.
https://doi.org/10.3390/ph13120425